Nuveen Asset Management, LLC Adaptive Biotechnologies Corp Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 354,842 shares of ADPT stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

354,842

Previous 553,761 35.92%

Holding current value

$1.77 Million

Previous $1.78 Million 27.74%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.34 - $3.96 $465,470 - $787,719	-198,919 Reduced 35.92%	354,842 $1.28 Million
Q1 2024 May 13, 2024	SELL	$2.88 - $4.8 $228,833 - $381,388	-79,456 Reduced 12.55%	553,761 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $13,905 - $21,421	4,019 Added 0.64%	633,217 $3.1 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $595,141 - $990,729	-117,385 Reduced 15.72%	629,198 $3.43 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $2.97 Million - $4.21 Million	-479,557 Reduced 39.11%	746,583 $5.01 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $3.27 Million - $4.24 Million	419,347 Added 51.98%	1,226,140 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $2.25 Million - $3.36 Million	359,342 Added 80.31%	806,793 $6.16 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $83,596 - $162,948	12,861 Added 2.96%	447,451 $3.19 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $702,515 - $1.62 Million	109,768 Added 33.79%	434,590 $3.52 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $223,894 - $639,383	22,124 Added 7.31%	324,822 $4.11 Million
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $1.06 Million - $1.55 Million	-42,034 Reduced 12.19%	302,698 $8.49 Million
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $1.61 Million - $2.13 Million	-53,523 Reduced 13.44%	344,732 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $681,807 - $943,568	21,161 Added 5.61%	398,255 $16.3 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $2.32 Million - $4.21 Million	-62,164 Reduced 14.15%	377,094 $15.2 Million
Q4 2020 May 17, 2021	BUY	$45.01 - $65.47 $1.98 Million - $2.87 Million	43,910 Added 11.11%	439,258 $26 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $5.36 Million - $7.79 Million	119,032 Added 43.08%	395,348 $23.4 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $878,930 - $1.2 Million	24,558 Added 9.75%	276,316 $13.4 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $390,143 - $756,518	15,637 Added 6.62%	251,758 $12.2 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $3.08 Million - $6.2 Million	181,567 Added 332.82%	236,121 $6.56 Million
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $37,675 - $50,315	-1,534 Reduced 2.73%	54,554 $1.63 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $1.29 Million - $2.29 Million	42,718 Added 319.51%	56,088 $1.73 Million
Q2 2019 Aug 15, 2019	BUY	$40.3 - $48.3 $538,811 - $645,771	13,370 New	13,370 $646,000

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $714M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Adaptive Biotechnologies Corp Transaction History